tradingkey.logo
tradingkey.logo
Search

Immunoprecise Antibodies Ltd

IPA
Add to Watchlist
2.070USD
0.0000.00%
Close 07/02, 13:00ETQuotes delayed by 15 min
95.54MMarket Cap
LossP/E TTM

Immunoprecise Antibodies Ltd

2.070
0.0000.00%
View Detailed Chart
TradingKey 图表
Intraday
1m
30m
1h
D
W
M
D

Today

0.00%

5 Days

0.00%

1 Month

0.00%

6 Months

0.00%

Year to Date

0.00%

1 Year

+89.91%

Key Figures
--Open
0.000High
0.00Volume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
4.44%Turnover Ratio
2.070Prev. Close
0.000Low
0.00Turnover
LossP/E Static
4.04P/B
0.00%Div Yield TTM
-57.90%ROA
3.24652wk High
1.19Volume Ratio
-30.23MNet Profit
46.15MShares
-0.9056EPS TTM
0.77Beta
-105.08%ROE
0.27052wk Low
12.18%Amplitude
47.31%Gross Margin
95.54MMarket Cap
0.30Reward/Risk
7.08%Risk Rate

TradingKey Stock Score

No stock score available due to insufficient data.

Immunoprecise Antibodies Ltd News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Immunoprecise Antibodies Ltd Info

ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies. It has several subsidiaries in North America and Europe including entities, such as Talem Therapeutics LLC, BioStrand BV, ImmunoPrecise Antibodies (Canada) Ltd. and ImmunoPrecise Antibodies (Europe) B.V. (collectively, the IPA Family). Its Contract Research Organizations (CRO) services include B cell Select; Phage Display; DeepDisplay; Abthena Bispecifics; LucinaTech Humanization; Affinity Maturation; Immunization, hybridoma, sequencing; rPEx protein manufacturing, and Cell line development. The Company utilizes custom antigen modeling, target analysis using Natural Language Processing and the HYFTTM analysis to lay the groundwork for the subsequent experimental phases.
Ticker SymbolIPA
CompanyImmunoprecise Antibodies Ltd
CEODr. Jennifer Lynne Bath, Ph.D.
Websitehttps://www.ipatherapeutics.com/

FAQs

What is the current price of Immunoprecise Antibodies Ltd (IPA)?

The current price of Immunoprecise Antibodies Ltd (IPA) is 2.07.

What is the symbol of Immunoprecise Antibodies Ltd?

The ticker symbol of Immunoprecise Antibodies Ltd is IPA.

What is the 52-week high of Immunoprecise Antibodies Ltd?

The 52-week high of Immunoprecise Antibodies Ltd is 3.25.

What is the 52-week low of Immunoprecise Antibodies Ltd?

The 52-week low of Immunoprecise Antibodies Ltd is 0.27.

What is the market capitalization of Immunoprecise Antibodies Ltd?

The market capitalization of Immunoprecise Antibodies Ltd is 95.54M.

Is Immunoprecise Antibodies Ltd (IPA) currently rated as Buy, Hold, or Sell?

According to analysts, Immunoprecise Antibodies Ltd (IPA) has an overall rating of Buy, with a price target of 4.00.

What is the Earnings Per Share (EPS TTM) of Immunoprecise Antibodies Ltd (IPA)?

The Earnings Per Share (EPS TTM) of Immunoprecise Antibodies Ltd (IPA) is -0.66.